Can phage-antibiotic combinations overcome uropathogenic Escherichia coli regrowth? evidence from in vitro and in vivo models. [PDF]
Makky S +6 more
europepmc +1 more source
Survival of ampicillin-treated uropathogenic Escherichia coli is independent of single-cell growth rates. [PDF]
Miyahara Y +5 more
europepmc +1 more source
Uropathogenic Escherichia coli invade luminal prostate cells via FimH-PPAP receptor binding. [PDF]
Guedes M +12 more
europepmc +1 more source
Preparation, characterization, and evaluation of chitosan-thymol nanoparticles for antibacterial and antibiofilm activities against catheter-associated uropathogenic Escherichia coli. [PDF]
Dini Y +6 more
europepmc +1 more source
Antibacterial Potential of Actinomycete Extracts and Characterization of β-Lactamase-Producing Multidrug-Resistant Uropathogenic Escherichia coli. [PDF]
Khaledi H, Obeid NO.
europepmc +1 more source
Cocktail of genetically diverse lytic phages reduces uropathogenic Escherichia coli colonization in mouse urinary tract. [PDF]
Mongkolkarvin P +8 more
europepmc +1 more source
Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli. [PDF]
Bazgosha M +10 more
europepmc +1 more source
Spatial clusters of dominant lineages of uropathogenic Escherichia coli in a community dwelling patient population. [PDF]
Belmont C +6 more
europepmc +1 more source
High Rates of Antimicrobial Resistance and Emergence of High-Risk Clones in Community-Acquired Uropathogenic Escherichia coli. [PDF]
Galvão VS +5 more
europepmc +1 more source
Uropathogenic Escherichia coli proliferate as a coccoid morphotype inside human host cells. [PDF]
Pokhrel A +5 more
europepmc +1 more source

